Novozymes A/S provided revenue guidance for 2022. Company expects an organic sales growth of 3-7% reflecting uncertainty related to the pandemic situation and volatile market conditions. Sales growth in Danish kroner is expected to be around 3 percentage point higher than the organic sales growth outlook of 3-7%.

The year is expected to be off to a good start.